tiprankstipranks
PAVmed Inc (PAVM)
NASDAQ:PAVM
US Market
PAVM
PAVmed
RESEARCH TOOLSreports
Want to see PAVM full AI Analyst Report?

PAVmed (PAVM) Ratios

693 Followers

PAVmed Ratios

PAVM's free cash flow for Q4 2025 was $-0.98. For the 2025 fiscal year, PAVM's free cash flow was decreased by $ and operating cash flow was $-130.83. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.17 0.17 0.06 0.45 1.07
Quick Ratio
 0.17 0.16 0.05 0.44 1.06
Cash Ratio
 0.10 103.66 0.03 0.36 0.96
Solvency Ratio
 0.03 0.03 1.09 -1.07 -2.01
Operating Cash Flow Ratio
 -430.63 -350.88 -0.95 -0.96 -1.72
Short-Term Operating Cash Flow Coverage
 -547.35 -9.09 -1.15 -1.18 -2.11
Net Current Asset Value
$ -13.96M$ -13.96M$ -35.53M$ -32.64M$ 880.00K
Leverage Ratios
Debt-to-Assets Ratio
 0.34 343.91 1.04 1.47 0.68
Debt-to-Equity Ratio
 0.39 392.97 -12.77 -0.91 -3.78
Debt-to-Capital Ratio
 0.28 1.00 1.08 -9.54 1.36
Long-Term Debt-to-Capital Ratio
 0.00 1.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.14 1.14 -12.29 -0.62 -5.58
Debt Service Coverage Ratio
 -0.55 -0.04 1.02 -1.69 -2.85
Interest Coverage Ratio
 -1.04K -1.04K -988.60 -116.80 -71.11
Debt to Market Cap
 2.67 3.01K 4.79 1.48 0.79
Interest Debt Per Share
 17.28 19.91K 98.96 204.58 191.56
Net Debt to EBITDA
 -1.85 -544.21 1.03 -0.38 0.03
Profitability Margins
Gross Profit Margin
-291.55%-354.93%-101.60%-161.83%-858.62%
EBIT Margin
-9153.52%-30712.68%950.65%-3208.56%-27044.30%
EBITDA Margin
-9005.63%-30564.79%990.65%-3088.99%-26392.57%
Operating Profit Margin
-30715.49%-30712.68%-1485.38%-2805.67%-24161.01%
Pretax Profit Margin
-3477.46%-3477.46%949.15%-3232.59%-27384.08%
Net Profit Margin
564.79%564.79%1328.58%-2617.25%-23602.92%
Continuous Operations Profit Margin
-3477.46%-3477.46%949.15%-3232.59%-27384.08%
Net Income Per EBT
-16.24%-16.24%139.98%80.96%86.19%
EBT Per EBIT
11.32%11.32%-63.90%115.22%113.34%
Return on Assets (ROA)
1.03%1.03%129.78%-193.77%-164.84%
Return on Equity (ROE)
1.02%1.18%-1594.83%119.22%919.15%
Return on Capital Employed (ROCE)
-90.96%-90.95%929.52%326.69%-712.73%
Return on Invested Capital (ROIC)
-61.18%-3.65%-179.19%-278.44%-191.48%
Return on Tangible Assets
1.03%1.03%129.78%-202.48%-176.08%
Earnings Yield
6.38%9.03%655.44%-215.40%-208.12%
Efficiency Ratios
Receivables Turnover
 4.73 4.73 166.39 40.20 22.18
Payables Turnover
 0.41 0.48 9.19 3.59 1.34
Inventory Turnover
 0.00 1.35 22.70 11.91 13.85
Fixed Asset Turnover
 0.03 <0.01 1.13 0.41 0.07
Asset Turnover
 <0.01 <0.01 0.10 0.07 <0.01
Working Capital Turnover Ratio
 >-0.01 >-0.01 -0.10 -0.18 <0.01
Cash Conversion Cycle
 -813.07 -418.97 -21.44 -61.82 -230.27
Days of Sales Outstanding
 77.11 77.11 2.19 9.08 16.46
Days of Inventory Outstanding
 0.00 270.08 16.08 30.64 26.36
Days of Payables Outstanding
 890.18 766.16 39.72 101.54 273.09
Operating Cycle
 77.11 347.19 18.27 39.72 42.82
Cash Flow Ratios
Operating Cash Flow Per Share
 -8.26K -7.76K -104.07 -215.87 -358.61
Free Cash Flow Per Share
 -8.26K -7.76K -104.24 -216.87 -366.39
CapEx Per Share
 0.05 0.05 0.17 1.00 7.78
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.02
Dividend Paid and CapEx Coverage Ratio
 -1.01K -167.94K -610.07 -215.02 -46.09
Capital Expenditure Coverage Ratio
 -172.68K -167.94K -610.07 -215.02 -46.09
Operating Cash Flow Coverage Ratio
 -478.67 -0.39 -1.05 -1.07 -1.94
Operating Cash Flow to Sales Ratio
 -89.99K -73.32K -11.20 -21.22 -188.29
Free Cash Flow Yield
-146337.85%-117292.28%-553.61%-175.46%-169.62%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 15.70 11.07 0.15 -0.46 -0.48
Price-to-Sales (P/S) Ratio
 61.57 62.51 2.03 12.15 113.41
Price-to-Book (P/B) Ratio
 0.19 0.13 -2.43 -0.55 -4.42
Price-to-Free Cash Flow (P/FCF) Ratio
 >-0.01 >-0.01 -0.18 -0.57 -0.59
Price-to-Operating Cash Flow Ratio
 >-0.01 >-0.01 -0.18 -0.57 -0.60
Price-to-Earnings Growth (PEG) Ratio
 -0.17 -0.10 >-0.01 0.01 >-0.01
Price-to-Fair Value
 0.19 0.13 -2.43 -0.55 -4.42
Enterprise Value Multiple
 -2.53 -544.42 1.24 -0.78 -0.40
Enterprise Value
 16.18M 11.81B 36.75M 58.88M 39.65M
EV to EBITDA
 -2.53 -544.42 1.24 -0.78 -0.40
EV to Sales
 227.83 166.40K 12.27 24.01 105.17
EV to Free Cash Flow
 >-0.01 -2.27 -1.09 -1.13 -0.55
EV to Operating Cash Flow
 >-0.01 -2.27 -1.10 -1.13 -0.56
Tangible Book Value Per Share
 28.82 33.26 -21.81 -105.55 37.83
Shareholders’ Equity Per Share
 43.91 50.66 -7.74 -223.32 -48.91
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.09 0.11 9.29 10.17 1.90
Net Income Per Share
 0.52 0.60 123.42 -266.23 -449.53
Tax Burden
 -0.16 -0.16 1.40 0.81 0.86
Interest Burden
 0.38 0.11 1.00 1.01 1.01
Research & Development to Revenue
 63.28 63.27K 1.98 5.82 67.21
SG&A to Revenue
 241.79K 241.79K 12.07 12.62 109.84
Stock-Based Compensation to Revenue
 13.23K 24.04K 2.15 4.54 51.81
Income Quality
 0.19 2.11 -1.18 0.66 0.69
Currency in USD